Residency · Residency · Otolaryngology

Vascular Anomalies of the Head and Neck in Children

Introduction

Vascular anomalies of the head and neck represent a diverse group of lesions that are among the most common congenital abnormalities encountered in pediatric otolaryngology. The International Society for the Study of Vascular Anomalies (ISSVA) classification system divides these lesions into two major categories: vascular tumors and vascular malformations. Accurate diagnosis is essential, as management strategies differ significantly between categories.

Classification

ISSVA Classification System

Vascular tumors: Lesions characterized by endothelial cell proliferation. Infantile hemangioma (most common vascular tumor of infancy). Congenital hemangioma (rapidly involuting [RICH] and non-involuting [NICH]). Kaposiform hemangioendothelioma. Tufted angioma. Vascular malformations: Structural anomalies of blood vessels without proliferation. Capillary malformations (port-wine stains). Venous malformations. Lymphatic malformations (macrocystic, microcystic, mixed). Arteriovenous malformations (AVMs). Combined malformations.

Key Distinguishing Features

Vascular tumors are not present at birth (or minimally so) and undergo a proliferative phase. Vascular malformations are always present at birth, grow proportionally with the child, and never involute spontaneously. GLUT-1 positivity is pathognomonic for infantile hemangioma.

Infantile Hemangiomas

Natural History

Appear within the first weeks of life. Proliferative phase: Rapid growth during months 1-9. Involuting phase: Gradual regression over years 1-5. Involuted phase: Completed by age 5-10; may leave residual fibrofatty tissue or telangiectasia. Up to 60% of head and neck hemangiomas occur in the parotid region.

Indications for Treatment

Airway compromise (subglottic hemangioma), Visual obstruction or amblyopia risk, Ulceration, bleeding, or infection, Significant cosmetic deformity.

Medical Management

Propranolol is first-line systemic therapy (dose: 2-3 mg/kg/day divided BID-TID). Topical timolol for superficial, small lesions. Systemic corticosteroids as second-line therapy. Monitor heart rate, blood pressure, and blood glucose during propranolol initiation.

Vascular Malformations

Lymphatic Malformations

Previously called cystic hygromas or lymphangiomas. Most common in the posterior triangle of the neck. Macrocystic lesions respond well to sclerotherapy (OK-432, doxycycline, bleomycin). Microcystic lesions are more difficult to treat and often require surgical excision. MRI is the imaging modality of choice; T2-weighted images show hyperintense cystic spaces.

Venous Malformations

Soft, compressible, blue-tinged masses that enlarge with Valsalva or dependent positioning. Phleboliths may be visible on imaging. Treatment options include sclerotherapy (sodium tetradecyl sulfate, ethanol) and surgical excision. Frequently recur after incomplete excision.

Arteriovenous Malformations

High-flow lesions with direct arteriovenous shunting. Staged according to the Schobinger classification (stages I-IV). May remain quiescent for years then expand rapidly after trauma, puberty, or pregnancy. Treatment requires preoperative embolization followed by complete surgical resection within 24-48 hours.

Diagnostic Workup

Ultrasound with Doppler: First-line imaging to distinguish high-flow from low-flow lesions. MRI with gadolinium: Gold standard for characterizing extent and tissue planes. CT angiography: Useful for AVMs to delineate feeding vessels. Biopsy: Rarely needed; reserved for atypical presentations or suspected malignancy. GLUT-1 immunostaining: Differentiates infantile hemangioma from other vascular tumors.

Surgical Considerations

Complete excision is curative but not always feasible due to infiltrative nature. Staged excision may be necessary for extensive malformations. Preoperative embolization reduces intraoperative blood loss for high-flow lesions. Airway hemangiomas may require open excision or CO2 laser ablation if refractory to propranolol. Multidisciplinary team approach (otolaryngology, interventional radiology, dermatology, plastic surgery) is recommended.

Key Clinical Pearls

Always classify vascular anomalies using the ISSVA system; avoid outdated terminology such as "cavernous hemangioma". Propranolol has revolutionized the management of infantile hemangiomas and should be initiated early during the proliferative phase. GLUT-1 positivity is the single most reliable marker distinguishing infantile hemangioma from vascular malformations. Segmental facial hemangiomas warrant evaluation for PHACE syndrome (posterior fossa anomalies, hemangioma, arterial anomalies, coarctation, eye abnormalities). Macrocystic lymphatic malformations respond well to sclerotherapy; microcystic lesions often require surgery.

References

1. Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128-140.
2. Wassef M, Blei F, Adams D, et al. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136(1):e203-e214.
3. Perkins JA, Manning SC, Tempero RM, et al. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg. 2010;142(6):795-803.
4. Richter GT, Friedman AB. Hemangiomas and vascular malformations: current theory and management. Int J Pediatr. 2012;2012:645678.

For the intern

At 3am, prioritize airway concerns: stridor with a known hemangioma needs immediate assessment and may require propranolol or emergent airway management. Rapid expansion of a lymphatic malformation (often triggered by upper respiratory infection) can compromise the airway—obtain urgent imaging and involve ENT. Bleeding from ulcerated hemangiomas can be managed with pressure and topical hemostatic agents; surgical intervention is rarely emergent. Most other vascular anomaly complaints—cosmetic concerns, stable swelling, or questions about treatment timing—can wait until morning when you can review imaging with the attending and coordinate multidisciplinary care.

Common pitfalls

• Confusing terminology: Avoid outdated terms like "cavernous hemangioma" or "cystic hygroma." Use ISSVA classification: vascular tumors (infantile hemangioma) versus vascular malformations (lymphatic, venous, arteriovenous). GLUT-1 staining definitively distinguishes infantile hemangioma from malformations.
• Missing PHACE syndrome: Segmental facial hemangiomas (especially in the beard distribution or covering >5 cm²) require cardiac evaluation and brain MRI/MRA. Coarctation and posterior fossa anomalies can be life-threatening.
• Treating all hemangiomas: Most involute spontaneously. Only treat when functionally or cosmetically significant—vision obstruction, airway compromise, ulceration, or disfiguring location. Starting propranolol during the proliferative phase (first 5 months) yields best results.
• Incomplete AVM resection: Partial excision of arteriovenous malformations causes catastrophic recurrence. Always coordinate preoperative embolization within 24–48 hours of complete surgical resection, or refer to a specialized center.

Make it stick

Imagine you're examining a 3-month-old with a bright red, raised lesion on her cheek that wasn't there at birth. Your initial thought should be "infantile hemangioma." Now, picture a newborn with a soft, bluish, compressible mass on his neck that has been present since birth. This points to a "vascular malformation," likely a lymphatic or venous type. The key differentiator is presence at birth and growth pattern—hemangiomas appear later and proliferate, then involute, while malformations are congenital and grow with the child without involuting.

If you remember one thing

Always classify vascular anomalies using the ISSVA system; this guides diagnosis and management, and helps avoid outdated or confusing terminology. Infantile hemangiomas are vascular tumors that are not present at birth, proliferate, then involute, and are GLUT-1 positive; vascular malformations are present at birth, grow proportionally, and do not involute.

Read this lecture as Markdown